TERT
MOLECULAR TARGETtelomerase reverse transcriptase
TERT (telomerase reverse transcriptase) is targeted by 13 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting TERT
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | epigalocatechin gallate | 5.40 | 220 |
| 2 | tanshinone iia | 3.74 | 41 |
| 3 | 78 dihydroxyflavone | 3.14 | 22 |
| 4 | costunolide | 3.00 | 19 |
| 5 | perifosine | 2.89 | 17 |
| 6 | Ethidium | 2.71 | 14 |
| 7 | allicin | 2.71 | 14 |
| 8 | acetylshikonin | 2.48 | 11 |
| 9 | acridine orange | 2.40 | 10 |
| 10 | 910 phenanthrenequinone | 2.30 | 9 |
| 11 | egcg | 1.61 | 4 |
| 12 | Oleic Acid | 0.69 | 1 |
| 13 | celastrol | 0.69 | 1 |
About TERT as a Drug Target
TERT (telomerase reverse transcriptase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 13 compounds with documented TERT interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
TERT inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.